Cargando…
N-(4-Hydroxyphenyl) Retinamide Potentiated Anti-Tumor Efficacy of Genistein in Human Ewing’s Sarcoma Xenografts
BACKGROUND: Ewing’s sarcoma is a pediatric tumor that mainly occurs in soft tissues and bones. New therapeutic strategies are urgently needed for treatment of Ewing’s sarcoma. We examined for the first time the efficacy of N-(4-hydroxyphenyl) retinamide (4-HPR) and genistein (GST) alone and also in...
Autores principales: | Karmakar, Surajit, Choudhury, Subhasree Roy, Banik, Naren L., Ray, Swapan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151019/ https://www.ncbi.nlm.nih.gov/pubmed/21822457 http://dx.doi.org/10.4021/wjon301w |
Ejemplares similares
-
Targeting Angiogenesis for Controlling Neuroblastoma
por: Roy Choudhury, Subhasree, et al.
Publicado: (2012) -
Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis
por: Asumendi, A, et al.
Publicado: (2002) -
4-oxo-N-(4-hydroxyphenyl)retinamide: Two Independent Ways to Kill Cancer Cells
por: Tiberio, Paola, et al.
Publicado: (2010) -
A NIR-responsive indocyanine green-genistein nanoformulation to control the polycomb epigenetic machinery for the efficient combinatorial photo/chemotherapy of glioblastoma
por: Kaundal, Babita, et al.
Publicado: (2019) -
Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
por: Favoni, R. E., et al.
Publicado: (1998)